News

CellVoyant was named the Innovation Incubator Winner for 2025 at the AI Drug Discovery & Development Summit for its work applying AI to label-free live-cell imaging and predictive cell analytics.

FateView™ the first online platform enabling AI-driven, predictive live cell analytics was publicly launch in September with a one-month free trial for new users.

CellVoyant was recognised as a 2024 WIRED Trailblazer.